Patents by Inventor Elisabeth Narayanan

Elisabeth Narayanan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RESPIRATORY VIRUS IMMUNIZING COMPOSITIONS
    Publication number: 20230338506
    Abstract: The disclosure relates to respiratory virus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: January 29, 2021
    Publication date: October 26, 2023
    Applicant: ModernaTX, Inc.
    Inventors: Christine Shaw, Guillaume Stewart-Jones, Elisabeth Narayanan, Vladimir Presnyak, Sayda Mahgoub Elbashir
  • CORONAVIRUS RNA VACCINES
    Publication number: 20230108894
    Abstract: The disclosure relates to coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: January 26, 2021
    Publication date: April 6, 2023
    Applicant: Moderna TX, Inc
    Inventors: Guillaume Stewart-Jones, Elisabeth Narayanan, Hamilton Bennett, Andrea Carfi, Mihir Metkar, Vladimir Presnyak
  • HIV RNA VACCINES
    Publication number: 20220241399
    Abstract: Provided herein are methods and compositions for inducing in a subject abroad neutralizing antibody response to human immunodeficiency virus (HIV) infection.
    Type: Application
    Filed: March 13, 2020
    Publication date: August 4, 2022
    Applicants: Moderna TX, Inc., The United States of America, as represented by the Department of Health and Human Services
    Inventors: Paolo Lusso, Peng Zhang, Elisabeth Narayanan, Sayda Mahgoub Elbashir
  • EPSTEIN-BARR VIRUS VACCINES
    Publication number: 20200282047
    Abstract: The disclosure relates to EBV ribonucleic acid vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: November 20, 2018
    Publication date: September 10, 2020
    Applicant: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Elisabeth Narayanan, Brooke Bollman
  • RNA BACTERIAL VACCINES
    Publication number: 20200038499
    Abstract: The disclosure relates to (i) a bacterial vaccine, comprising: at least one RNA polynucleotide having an open reading frame encoding at least one mutated bacterial antigenic polypeptide, wherein the mutated bacterial antigenic polypeptide comprises at least one asparagine (Asn) amino acid substitution; and (ii) a Streptococcal vaccine, comprising: at least one RNA polynucleotide having an open reading frame encoding at least one Streptococcal antigenic polypeptide, such as pneumolysin. Incorporating the RNA in a cationic lipid nanoparticle and a method of inducing an immune response with said vaccine are also disclosed.
    Type: Application
    Filed: March 22, 2018
    Publication date: February 6, 2020
    Applicant: ModernaTX, Inc.
    Inventors: Elisabeth Narayanan, Nadia Cohen, Giuseppe Ciaramella
  • SALMONELLA VACCINES
    Publication number: 20190192646
    Abstract: The disclosure relates to Salmonella ribonucleic acid vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: November 5, 2018
    Publication date: June 27, 2019
    Applicant: ModernaTX, Inc.
    Inventors: Nadia Cohen, Marie-Angele Andjoua Messou, Samantha Calabrese, Elisabeth Narayanan